MIAMI--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that Peter Brandt, Noven’s President & Chief Executive Officer, is scheduled to present an update on Noven’s business and prospects at the UBS Global Life Sciences Conference in New York City on Monday, September 22nd at 12:30 p.m. ET. The presentation will be webcast live at www.noven.com, and a rebroadcast will be available thereafter for at least two weeks at the same site.
